These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27144941)

  • 1. Plakoglobin Reduces the in vitro Growth, Migration and Invasion of Ovarian Cancer Cells Expressing N-Cadherin and Mutant p53.
    Alaee M; Danesh G; Pasdar M
    PLoS One; 2016; 11(5):e0154323. PubMed ID: 27144941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The physical interaction of p53 and plakoglobin is necessary for their synergistic inhibition of migration and invasion.
    Alaee M; Padda A; Mehrabani V; Churchill L; Pasdar M
    Oncotarget; 2016 May; 7(18):26898-915. PubMed ID: 27058623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plakoglobin induces desmosome formation and epidermoid phenotype in N-cadherin-expressing squamous carcinoma cells deficient in plakoglobin and E-cadherin.
    Parker HR; Li Z; Sheinin H; Lauzon G; Pasdar M
    Cell Motil Cytoskeleton; 1998; 40(1):87-100. PubMed ID: 9605974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plakoglobin restores tumor suppressor activity of p53
    Alaee M; Nool K; Pasdar M
    Cancer Sci; 2018 Jun; 109(6):1876-1888. PubMed ID: 29660231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells.
    Cheng JC; Auersperg N; Leung PC
    Oncogene; 2011 Sep; 30(37):3930-42. PubMed ID: 21478913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing MTA1 by RNAi reverses adhesion, migration and invasiveness of cervical cancer cells (SiHa) via altered expression of p53, and E-cadherin/β-catenin complex.
    Rao Y; Wang H; Fan L; Chen G
    J Huazhong Univ Sci Technolog Med Sci; 2011 Feb; 31(1):1-9. PubMed ID: 21336715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin.
    Cheng JC; Auersperg N; Leung PC
    Oncogene; 2011 Mar; 30(9):1020-31. PubMed ID: 20972462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plakoglobin represses SATB1 expression and decreases in vitro proliferation, migration and invasion.
    Aktary Z; Pasdar M
    PLoS One; 2013; 8(11):e78388. PubMed ID: 24260116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
    Murali AK; Norris JS
    J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells.
    Roger L; Jullien L; Gire V; Roux P
    J Cell Sci; 2010 Apr; 123(Pt 8):1295-305. PubMed ID: 20332115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.
    de Groot JS; Ratze MA; van Amersfoort M; Eisemann T; Vlug EJ; Niklaas MT; Chin SF; Caldas C; van Diest PJ; Jonkers J; de Rooij J; Derksen PW
    J Pathol; 2018 Aug; 245(4):456-467. PubMed ID: 29774524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of cysteine 457 in plakoglobin modulates the proliferation and migration of colorectal cancer cells by altering binding to E-cadherin/catenins.
    Kim S; Ahn SH; Yang HY; Lee JS; Choi HG; Park YK; Lee TH
    Redox Rep; 2017 Nov; 22(6):272-281. PubMed ID: 27571934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression.
    Kokenyesi R; Murray KP; Benshushan A; Huntley ED; Kao MS
    Gynecol Oncol; 2003 Apr; 89(1):60-72. PubMed ID: 12694655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
    Sarrió D; Moreno-Bueno G; Sánchez-Estévez C; Bañón-Rodríguez I; Hernández-Cortés G; Hardisson D; Palacios J
    Hum Pathol; 2006 Aug; 37(8):1042-9. PubMed ID: 16867867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer.
    Malgundkar SH; Burney I; Al Moundhri M; Al Kalbani M; Lakhtakia R; Okamoto A; Tamimi Y
    BMC Cancer; 2020 May; 20(1):374. PubMed ID: 32366234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell adhesion molecule profiles, proliferation activity and p53 expression in advanced epithelial ovarian cancer induced malignant ascites-Correlation of tissue microarray and cytology microarray.
    Toth L; Nagy B; Mehes G; Laszlo E; Molnar PP; Poka R; Hernadi Z
    Pathol Res Pract; 2018 Jul; 214(7):978-985. PubMed ID: 29801775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activin A promotes ovarian cancer cell migration by suppressing E-cadherin expression.
    Yi Y; Cheng JC; Klausen C; Leung PCK
    Exp Cell Res; 2019 Sep; 382(2):111471. PubMed ID: 31229504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LSD1-mediated epigenetic modification contributes to ovarian cancer cell migration and invasion.
    Li Y; Wan X; Wei Y; Liu X; Lai W; Zhang L; Jin J; Wu C; Shao Q; Shao G; Lin Q
    Oncol Rep; 2016 Jun; 35(6):3586-92. PubMed ID: 27109588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells.
    Wang Y; Sheng Q; Spillman MA; Behbakht K; Gu H
    Oncogene; 2012 May; 31(20):2512-20. PubMed ID: 21996746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells.
    Sommers CL; Gelmann EP; Kemler R; Cowin P; Byers SW
    Cancer Res; 1994 Jul; 54(13):3544-52. PubMed ID: 8012979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.